Xinxing Q. Li
800 Xiang Yin Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Dietary yacon concentrate reshapes microbial-metabolite crosstalk to inhibit colorectal cancer.
Journal: NPJ science of food
Published: November 12, 2025
T Cell Exhaustion and Dendritic Cell-Mediated Tertiary Lymphoid Structures (TLSs) Modulation Affect Response to Neoadjuvant Chemoradiotherapy in Microsatellite Stable Rectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 28, 2025
Clinical Stage Prompt Induced Multi-Modal Prognosis.
Journal: IEEE transactions on medical imaging
Published: July 14, 2025
Malignant epithelia cells-derived spermine induces APOE+ macrophages to suppress tumor immunity in adenocarcinoma of the esophagogastric junction.
Journal: Frontiers in medicine
Published: June 25, 2025
Copy number alteration fingerprint predicts the clinical response of oxaliplatin-based chemotherapy in metastatic colorectal cancer.
Journal: NPJ precision oncology
Published: May 26, 2025
A GaN Schottky Barrier Diode-Based Terahertz Metasurface for High-Precision Phase Control and High-Speed Beam Scanning.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 21, 2025
Immune-related deubiquitylation spectrum of microsatellite stability colorectal cancer reveals USP7 as a potential immunotherapeutic target.
Journal: Molecular cancer
Published: April 15, 2025
Tumor Immune Contexture Model Predicts Prognosis and Immunotherapy Response in Gastric Cancer.
Journal: The journal of gene medicine
Published: April 11, 2025
Integrated Multi-Omics Profiling to Characterize Molecular Subtypes and Reveal Potential Therapeutic Strategies for Colorectal Cancer.
Journal: MedComm
Published: February 13, 2025
p53 inhibits OTUD5 transcription to promote GPX4 degradation and induce ferroptosis in gastric cancer.
Journal: Clinical and translational medicine
Published: November 07, 2024
TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma.
Journal: Cell death & disease
Published: November 07, 2024
Last Updated: 09/26/2026